(Q34455157)

2 August 2017

1 reference

title

Conditional gene targeting for cancer gene therapy (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

Haviv YS

1

1 reference

PubMed ID

11731024

2 August 2017

Curiel DT

series ordinal

2

1 reference

PubMed ID

11731024

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Advanced Drug Delivery Reviews

2 August 2017

1 reference

2 August 2017

53

1 reference

2 August 2017

135-154

1 reference

2 August 2017

2

1 reference

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Recent advances in cancer research: drug targeting without the use of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Targeting of adenoviral vectors through a bispecific single-chain antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Targeting retroviral integration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Pseudotyped retroviral vectors for studies of human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Progress in transcriptionally targeted and regulatable vectors for genetic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Positive genetic selection for gene disruption in mammalian cells by homologous recombination

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Gene therapy: designer promoters for tumour targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Endothelial cell-specific expression of tumor necrosis factor-alpha from the KDR or E-selectin promoters following retroviral delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Endothelial cell-specific transcriptional targeting from a hybrid long terminal repeat retrovirus vector containing human prepro-endothelin-1 promoter sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Genomic analysis of metastasis reveals an essential role for RhoC

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Endoglin expression as a measure of microvessel density in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Integrins and signal transduction pathways: the road taken

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Thrombin receptor overexpression in malignant and physiological invasion processes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Liposomes modified with a synthetic Arg-Gly-Asp mimetic inhibit lung metastasis of B16BL6 melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Ligand binding regulates the directed movement of beta1 integrins on fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Tyrosine kinase activity, cytoskeletal organization, and motility in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Agonist-stimulated cytoskeletal reorganization and signal transduction at focal adhesions in vascular smooth muscle cells require c-Src

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Differential effect on U937 cell differentiation by targeting transcriptional factors implicated in tissue- or stage-specific induced integrin expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Suppression of tumor growth through disruption of hypoxia-inducible transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

DNA replication control through interaction of E2F-RB and the origin recognition complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Hexokinase type II: a novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Molecular chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Identification of the secretory leukocyte protease inhibitor (SLPI) as a target of IRF-1 regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Regulation of Bcl-2 gene expression by BCR-ABL is mediated by Ras.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Negative regulation of bcl-2 expression by p53 in hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Molecular targets for breast cancer therapy and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Gene therapy of murine teratocarcinoma: separate functions for insulin-like growth factors I and II in immunogenicity and differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

High level expression of tissue inhibitors of metalloproteinases-1,-2 and -3 in melanoma cells achieved by adenovirus mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Inhibition of melanoma tumor growth in vivo by survivin targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Evaluation of Relative Promoter Strength in Primary Hepatocytes Using Optimized Lipofection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Therapeutic strategies using c-erbB-2 promoter-controlled drug activation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

In vivo adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

The dominant negative H-ras mutant, N116Y, suppresses growth of metastatic human pancreatic cancer cells in the liver of nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Engineering tissue-specific expression of a recombinant adenovirus: selective transgene transcription in the pancreas using the amylase promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Repression of Cyclooxygenase-2 and Prostaglandin E2Release by Dexamethasone Occurs by Transcriptional and Post-transcriptional Mechanisms Involving Loss of Polyadenylated mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Selective induction of toxicity to human cells expressing human immunodeficiency virus type 1 Tat by a conditionally cytotoxic adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Intracellular antibodies against HIV-1 envelope protein for AIDS gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Factors controlling the expression of mouse mammary tumour virus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Genetic prodrug activation therapy for breast cancer: A phase I clinical trial of erbB-2-directed suicide gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Noninvasive gene targeting to the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Efficient transfection of human interferon-beta gene to human glioma cells by means of cationic multilamellar liposomes coupled with a monoclonal antibody [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Cell-type-specific and regulatable transgenesis in the adult brain: adenovirus-encoded combined transcriptional targeting and inducible transgene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Bone tissue specific transcriptional control: options for targeting gene therapy to the skeleton

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Activation of the radiosensitive EGR-1 promoter induces expression of the herpes simplex virus thymidine kinase gene and sensitivity of human glioma cells to ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Targeting gene expression to tumor cells with loss of wild-type p53 function

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Eradication of breast cancer xenografts by hyperthermic suicide gene therapy under the control of the heat shock protein promoter.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Mdr1 promoter-driven tumor necrosis factor-alpha expression for a chemotherapy-controllable combined in vivo gene therapy and chemotherapy of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Regulation of multidrug resistance 1 (MDR1)/P-glycoprotein gene expression and activity by heat-shock transcription factor 1 (HSF1)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Inducible control of gene expression: prospects for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Glucocorticoids stimulate p21 gene expression by targeting multiple transcriptional elements within a steroid responsive region of the p21waf1/cip1 promoter in rat hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

A regulatory system for target gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Ligand-dependent regulation of plasmid-based transgene expression in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Adenovirus-mediated regulable target gene expression in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Reovirus therapy of tumors with activated Ras pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Evaluation of E1-mutant adenoviruses as conditionally replicating agents for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Tumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900225-3

7 January 2021

10.1016/S0169-409X(01)00225-3

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11731024